F.A.S.T.-BE FAST Stroke Warning Signs Study
F.A.S.T.-BE FAST Consumer Stroke Warning Signs Study
1 other identifier
interventional
2,000
1 country
1
Brief Summary
The goal of this randomized controlled trial is to learn whether the BE FAST (Balance, Eyes, Face, Arm, Speech, and Time) acronym works at least as well or better than the F.A.S.T. (Face drooping, Arm weakness, Speech difficulty, Time to call 911) acronym in helping participants learn and remember the warning signs of a stroke. The main questions it aims to answer are:
- Does the BE FAST acronym increase understanding among participants that calling 911 is the right first step they should take if a stroke is suspected?
- Does the BE FAST acronym perform as well as or better than the F.A.S.T. acronym in helping participants remember stroke warning signs on a letter-aided open-ended basis? Researchers will compare the BE FAST acronym to the F.A.S.T. acronym to see if the BE FAST acronym works at least as well as the F.A.S.T. acronym in teaching participants about the warning signs of a stroke and the importance of calling 911 if they suspect a stroke. Participants will:
- Take a survey about their knowledge of stroke and its symptoms
- Watch a short video about one of the acronyms and then answer more questions about what they learned
- Take another survey after 30 days about the acronym they learned about
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 28, 2024
CompletedFirst Submitted
Initial submission to the registry
April 25, 2024
CompletedFirst Posted
Study publicly available on registry
July 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedJuly 3, 2024
June 1, 2024
4 months
April 25, 2024
June 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Intent to Call 911 30-Days Post Education
The identification of calling 9-1-1 as the accurate immediate action to stroke being suspected at 30-days post-educational intervention. Outcome is not being reported on a scale. We are using dichotomous coding of correct or incorrect response, with the response of "Call 9-1-1" being the correct response from the pick list.
30 days
Secondary Outcomes (1)
Warning Signs Net Positive Accuracy Score 30-Days Post Education
30 days
Other Outcomes (2)
Intent to Call 911 Immediately Post-Education
Immediately after intervention
Change in Warning Signs Net Positive Accuracy Score Immediately Post-Education
Immediately after intervention
Study Arms (2)
BE FAST Group
EXPERIMENTALThe experimental BE FAST acronym education messaging, including 5 stroke warning signs and a call-to-action to call 911, will be shown to the participants using a brief video.
F.A.S.T. Group
ACTIVE COMPARATORThe comparator F.A.S.T. acronym education messaging, including 3 stroke warning signs and a call-to-action to call 911, will be shown to the participants using a brief video.
Interventions
A 1-minute educational video format using BE FAST. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
A 1-minute educational video format using F.A.S.T. Each acronym will be visually displayed in the video and audio voice over of each letter and corresponding phrase will be audible in English. The look, feel, and messaging in each video will be the same except for the acronyms.
Eligibility Criteria
You may qualify if:
- Able and willing to provide written informed consent;
- Have access to a computer, tablet or mobile device with internet services;
- Proficient in reading and writing the English language; and
- Reside outside a medical facility.
You may not qualify if:
- Not able to provide written informed consent;
- Do not have access to a computer, tablet or mobile device with internet;
- Not proficient in reading and writing in English language; or
- Reside in a medical facility.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
American Heart Association
Dallas, Texas, 75231, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Opeolu Adeoye, MD
Washington University School of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 25, 2024
First Posted
July 3, 2024
Study Start
March 28, 2024
Primary Completion
July 31, 2024
Study Completion
July 31, 2024
Last Updated
July 3, 2024
Record last verified: 2024-06
Data Sharing
- IPD Sharing
- Will not share